Subject(s)
Diabetes Mellitus, Type 2/blood , Diabetes Mellitus, Type 2/therapy , Glycated Hemoglobin/analysis , Phytotherapy , Chromium/therapeutic use , Cinnamomum zeylanicum , Humans , Ipomoea batatas , Silybum marianum , Randomized Controlled Trials as Topic , Safflower Oil , Trace Elements/therapeutic use , TrigonellaSubject(s)
Acute Coronary Syndrome/blood , Acute Coronary Syndrome/diagnosis , Creatine Kinase/blood , Myocardial Infarction/blood , Myocardial Infarction/diagnosis , Troponin/blood , Biomarkers/blood , Cohort Studies , Evidence-Based Medicine , Humans , Prospective Studies , Sensitivity and Specificity , Serologic TestsABSTRACT
Patients with elevated troponin levels and chronic renal disease, pulmonary hypertension, pulmonary embolism, chronic obstructive pulmonary disease, sepsis, or acute ischemic stroke have a 2- to 5-fold increased risk of death, even in the absence of known cardiovascular disease.
Subject(s)
Brain Ischemia/blood , Hypertension, Pulmonary/blood , Kidney Failure, Chronic/blood , Pulmonary Disease, Chronic Obstructive/blood , Pulmonary Embolism/blood , Stroke/blood , Troponin T/blood , Bacteremia/blood , Bacteremia/mortality , Biomarkers/blood , Brain Ischemia/mortality , Cardiovascular Diseases/blood , Clinical Trials as Topic , Evidence-Based Medicine , Guidelines as Topic , Humans , Hypertension, Pulmonary/mortality , Kidney Failure, Chronic/mortality , Predictive Value of Tests , Prognosis , Pulmonary Disease, Chronic Obstructive/mortality , Pulmonary Embolism/mortality , Risk Assessment , Risk Factors , Sensitivity and Specificity , Stroke/mortality , Survival Rate , United States/epidemiologyABSTRACT
Conservative measures--followed by corticosteroid injection, if necessary--are best. Conservative therapy includes rest, nonsteroidal anti-inflammatory drugs (NSAIDs), and stretching exercises focused on the lower back and sacroiliac joints. Patients whose symptoms persist despite conservative therapy are likely to benefit from an injection of 24 mg betamethasone and 1% lidocaine (or equivalent) into the inflamed bursa. In rare cases of intractable symptoms, surgical procedures such as iliotibial band release, subgluteal bursectomy, and trochanteric reduction osteotomy are options.
Subject(s)
Anti-Inflammatory Agents, Non-Steroidal/therapeutic use , Bursitis/therapy , Glucocorticoids/administration & dosage , Hip Joint , Orthopedic Procedures/methods , Humans , Injections, Intra-ArticularABSTRACT
Yes, treatment can increase a child's final height. Injections of recombinant human growth hormone (rGH) at least 3 times a week for 4 to 6 years add 3.7 to 7.5 cm to final height in children between 8 and 16 years of age with idiopathic short stature (strength of recommendation [SOR]: 2 small, low-quality, randomized controlled trials [RCTs]). This population comprises children who are otherwise physically and developmentally normal with a height standard deviation score (SDS) of Subject(s)
Body Height/drug effects
, Growth Disorders/drug therapy
, Growth Hormone/therapeutic use
, Humans
Subject(s)
Bed Rest , Pre-Eclampsia/prevention & control , Adult , Canada , Female , Gestational Age , Humans , Pregnancy , Pregnancy Complications , Pregnancy OutcomeSubject(s)
Hyperlipidemias/drug therapy , Hypolipidemic Agents/therapeutic use , Anion Exchange Resins/pharmacology , Anion Exchange Resins/therapeutic use , Azetidines/pharmacology , Azetidines/therapeutic use , Clofibric Acid/pharmacology , Clofibric Acid/therapeutic use , Evidence-Based Medicine , Ezetimibe , Fatty Acids, Omega-3/pharmacology , Fatty Acids, Omega-3/therapeutic use , Garlic , Humans , Hypolipidemic Agents/pharmacology , Niacin/pharmacology , Niacin/therapeutic use , Phytotherapy , Plant Preparations/pharmacology , Plant Preparations/therapeutic useABSTRACT
Percutaneous vertebroplasty has been used to treat aggressive vertebral hem-angiomas, osteoporotic vertebral compression fractures, and vertebral lesions from metastatic disease or myeloma. Consider it for patients with severe acute or chronic pain related to one of these lesions who have failed a reasonable course of medical therapy (strength of recommendation [SOR]: B, based on structured reviews of observational studies). Contraindications include an uncorrectable coagulation disorder, infection in the area, spinal cord compression, destruction of the posterior wall of the vertebral body, and severe degrees of vertebral body collapse (SOR: B, based on structured reviews of observational studies). Pain relief from vertebroplasty for osteoporotic vertebral fractures may be less for older fractures (SOR: C).
